share_log
  • Headlines
  • Huaren Pharmaceutical (300110.SZ) released its performance for the first three quarters, with a net income of 95.531 million yuan, a decrease of 30.31%.

华仁药业(300110.SZ)发布前三季度业绩，净利润9553.1万元，下降30.31%

Huaren Pharmaceutical (300110.SZ) released its performance for the first three quarters, with a net income of 95.531 million yuan, a decrease of 30.31%.

Zhitong Finance ·  Oct 28 20:26

huaren pharmaceutical (300110.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 1...

Zhixun Finance APP news, huaren pharmaceutical (300110.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 1.074 billion yuan, a decrease of 11.70% year-on-year. The net income attributable to the shareholders of the listed company was 95.531 million yuan, a decrease of 30.31% year-on-year. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 89.9778 million yuan, a decrease of 28.66% year-on-year. The basic earnings per share was 0.0808 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated